GI
SCMP

GAMCO Investors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

GAMCO Investors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-29,400
Closed -$528K – 868
2017
Q4 		$528K Buy
+29,400
New +$362K ﹤0.01% 674

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

GAMCO Investors's SCMP Position: Q1 2018 in Review

GAMCO Investors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 29,400 shares — an estimated $528K sold.

GAMCO Investors first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $528K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • GAMCO Investors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • GAMCO Investors sold 29,400 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $528K.
  • GAMCO Investors first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • GAMCO Investors's Sucampo Pharmaceuticals, Inc. position peaked at $528K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on GAMCO Investors's 13F filing for Q1 2018, filed 9 May 2018.